the Irradiation of Two Cases of Gliosarcoma: Place and Modalities of Radiotherapy | Zendy

Rajae En Nouichi | Zendy; Ghita Chbihi Hassani | Zendy; Fadwa Allouche | Zendy; M. Ait Erraisse | Zendy; Z. Alami | Zendy; Fz. Farhane | Zendy; Pr. T. Bouhafa | Zendy; Pr. K. Hassouni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

the Irradiation of Two Cases of Gliosarcoma: Place and Modalities of Radiotherapy

Author(s) -

Rajae En Nouichi,

Ghita Chbihi Hassani,

Fadwa Allouche,

M. Ait Erraisse,

Z. Alami,

Fz. Farhane,

Pr. T. Bouhafa,

Pr. K. Hassouni

Publication year - 2020

Publication title -

journal of medical biomedical and applied sciences

Language(s) - English

Resource type - Journals

ISSN - 2349-0748

DOI - 10.15520/jmbas.v8i6.232

Subject(s) - gliosarcoma , glioblastoma , parenchyma , radiation therapy , medicine , chemotherapy , pathology , radiology , cancer research

Gliosarcoma is a rare histopathologic variant of glioblastoma traditionally associated with a poor prognosis.We present two cases of Gliosarcoma treated in our department. Discussion: Gliosarcoma (GSM) is a variant of glioblastoma (GBM), the most common primary malignant brain tumor that occurs in adults. GSM is characterized by its biphasic components: the gliomatous and sarcomatous components and categorized into primary and secondary GSM. Intrinsic to the brain parenchyma, GSM is usually managed by gross total resection, and radiotherapy with/without chemotherapy. Conclusion: Despite the notable advances and improvement in overall survival (OS), a consensus on the optimal treatment for GSM patients is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research